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Thyroid hormone receptors are encoded by the TRa (NR1A1) and TRb (NR1A2) loci. These genes are
transcribed into multiple variants whose functions are unclear. Analysis by gene inactivation in mice has
provided new insights into the functional complexity of these products. Different strategies designed to modify
the TRa locus have led to strikingly different phenotypes. In order to analyze the molecular basis for these
alterations, we generated mice devoid of all known isoforms produced from the TRa locus (TRa0/0). These mice
are viable and exhibit reduced linear growth, bone maturation delay, moderate hypothermia, and reduced
thickness of the intestinal mucosa. Compounding TRa0 and TRb2 mutations produces viable TRa0/0b2/2
mice, which display a more severe linear growth reduction and a more profound hypothermia as well as
impaired hearing. A striking phenotypic difference is observed between TRa0/0 and the previously described
TRa2/2 mice, which retain truncated TRDa isoforms arising from a newly described promoter in intron 7. The
lethality and severe impairment of the intestinal maturation in TRa2/2 mice are rescued in TRa0/0 animals.
We demonstrate that the TRDa protein isoforms, which are natural products of the TRa locus, are the key
determinants of these phenotypical differences. These data reveal the functional importance of the non-T3-
binding variants encoded by the TRa locus in vertebrate postnatal development and homeostasis.
Thyroid hormone receptors (TRs), encoded by the TRa and
TRb loci, mediate the action of triiodothyronine (T3) in all
vertebrates. These nuclear proteins activate or repress the
transcription of target genes by recruiting several protein com-
plexes which modify the structure of chromatin (15). In mam-
mals, T3 exerts homeostatic and developmental functions.
Thyroid hormone (TH) deprivation leads to developmental
(growth retardation, impaired neurogenesis) (8, 23, 36) or met-
abolic (reduced oxygen consumption, bradycardia, weakness,
fatigue) disorders (13). Point mutations in the TRb gene result
in syndromes known as resistance to thyroid hormone (30).
Recently, the introduction of mutations in the genes encoding
these receptors in mice has allowed further understanding of
the mechanisms mediating the physiological actions of T3 (17,
19). The TRb locus encodes the TRb1 and TRb2 receptors. A
new receptor, TRb3, and its non-DNA-binding TRDb3 variant
have recently been described. The latter isoforms are proposed
to arise from a novel promoter located upstream of the exons
encoding the DNA binding domain (41). Genetic invalidation
of the TRb2 gene leads to pituitary resistance to TH with
elevated thyrotropin (TSH) and thyroxine (T4) levels in serum
(1). Knocking out all TRb1, TRb2, and TRb3/Db3 genes re-
produces this phenotype (10, 14) but also induces the loss of
auditory function, due to delayed expression of a potassium
channel in the cochlea (11), and results in impaired transcrip-
tional response to T3 in liver (38). The TRa locus encodes the
ubiquitous TRa1 receptor and a splice variant, TRa2, which
cannot bind T3 and behaves as a weak inhibitor of TRs in
transfection assays (21, 22). We have previously shown that, in
a limited number of tissues, the TRa locus also encodes two
transcripts, previously characterized by Northern blotting,
RNase protection, and reverse transcription (RT)-PCR anal-
ysis in embryonic stem (ES) cells, driven by a promoter located
in intron 7, which generate TRDa1 and TRDa2 proteins.
These proteins do not bind DNA or T3; hence, they are inhib-
itors of the activities of TRs and retinoic acid receptors in
transfection assays (6). In vivo genetic modifications of the
TRa locus result in different phenotypes, according to the
precise location of the mutation. In TRa2/2 mice, the expres-
sion of TRa1 and TRa2 transcripts is abolished, but the TRDa
transcripts are still expressed (12). These mice suffer from
hypothyroidism and display several developmental defects, in-
cluding growth retardation, altered intestinal development
(28), impaired T- and B-lymphocyte maturation (3), expansion
of cartilage regions in long bones, and finally growth arrest and
death shortly after weaning (12). Mice which lack the TRa1
and TRDa1 products (TRa12/2) have been reported to exhibit
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mild hypothyroxinemia, bradycardia, and lower body temper-
ature, but they display normal growth and life span (39). The
lethal phenotype of TRa2/2 mice compared to the viability of
TRa12/2 mice might be attributed to the deeper hypothyrox-
inemia of the former. The involvement of TH as the cause of
this phenotypic discrepancy can be ruled out. Indeed, although
TRa2/2b2/2 and TRa12/2b2/2 mice both lack the known
TRs and have very high serum levels of TH, TRa2/2b2/2 mice
die upon weaning (14), whereas TRa12/2b2/2 mice are viable
(16). Hence, the phenotypic differences must be ascribed to
structural differences between the TRa mutant alleles. They
could be attributed either to the TRa2 isoform, which is ex-
pressed in TRa12/2 but not in TRa2/2 mice, or to the balance
between the TRa and TRDa isoforms. In an attempt to deter-
mine the role of the non-T3-binding products, we have gener-
ated a new mouse strain harboring a targeted deletion de-
signed to prevent the expression of all transcripts from the TRa
locus. In this paper we describe the phenotype of these TRa0/0
mutant mice and point out similarities and striking differences
with previously described TRa12/2 and TRa2/2 mice. This
comparative analysis brings a new piece in the genetic analysis
of the complex TRa locus and sheds new light on the respective
functions of the TRa products in body growth, bone matura-
tion, thermogenesis, audition, and intestinal maturation.
MATERIALS AND METHODS
Targeted disruption of TRa gene. The TRa0-targeting vector was constructed
using pGNAb as starting plasmid (gift from P. Brulet, Institut Pasteur, Paris,
France). The 39 arm homologous to TRa was amplified by PCR from ENS ES
cell DNA (14), using the Expand High Fi system (Roche). The 59 arm was cloned
from a lEMBL4 library (gift from J. P Magaud). The thymidine kinase gene was
inserted downstream of the 39 arm.
ENS ES cells were electroporated with 40 mg of linearized targeting vector and
then selected with 250 mg of G418 (Gibco-BRL) per ml and 0.2 mM ganciclovir.
Targeted clones were confirmed by Southern blot analysis using PvuII enzyme
and a 900-bp PCR fragment extending from the 39 end of exon 3 to the 59 end
of exon 4 of TRa as a probe. Two positive clones were injected into blastocysts
of C57BL/6 recipient mice. TRa0/1 animals were derived in an inbred 129sv
background. TRa0/0 mice were obtained by intercrossing heterozygous animals.
Mouse breeding and handling were carried out in a certified animal facility,
according to procedures approved by the local animal care and use committee.
Purification of RNA, Northern blotting RNase protection assay, and RT-PCR
analysis. Total RNA from distal small intestine or pituitary was isolated by the
improved acid-guanidine-phenol-chloroform method. For Northern blot analy-
sis, single-stranded DNA probes were generated by a 30-cycle reaction using Taq
DNA polymerase from Eurobio using 10 ng of TRa (exon 8), growth hormone
(GH), or hypoxanthine phosphoribosyltransferase (HPRT) PCR fragments as a
template, and 20 ng of a specific antisense primer: oligonucleotides a15A (CA
GCCTGCAGCAGAGCCACTTCCG), GHa (GTCAAACTTGTCATAGGTT
TG), and HPRTa (CACAGGACTAGAACACCTGC) were used as primers to
generate the TRa, GH, and HPRT probes, respectively.
RNase protection was performed using reagents from Ambion (Austin, Tex.)
according to the manufacturer’s instructions. HPRT and TRa cDNA fragments
were generated by RT-PCR and inserted into a pGEMt easy vector (Promega).
Oligonucleotides HPRTs (GCTGGTGAAAAGGACCTCT) and HPRTa (see
above) were used to generate the HPRT fragment, and TRaCs (CTCTGTGA
TCCTGCTGTTCCACAG) and TRa1a (CGACTTTCATGTGGAGGAAG)
were used to generate the TRa cDNA.
RT was performed as described in reference 12. cDNA (0.05 mg) was used for
each PCR with Eurobio Taq. To allow the detection of TRa gene products
(TRa1, TRa2, TRDa1, and TRDa2) by RT-PCR, we used a sense primer within
exon 8 (a29, CTGCCTTGCGAAGACCAGATC) and an antisense primer
within exon 9 (a3, GCGGTGGTTGACGTAGTGCTC). All the oligonucleo-
tides were purchased from MWG (Ebersberg, Germany).
Morphological analysis of long bones and growth plate cartilage. Skin and
muscle were dissected from forelimbs and hindlimbs of 3-week-old wild-type and
TRa0/0 null mice. For anatomical analysis of long bones, one upper and one
lower limb from each animal were fixed in 80% ethanol for 1 to 4 days and
transferred to 95% ethanol for a further 1 to 8 days, followed by acetone for 1 to
2 days at 4°C. Fixed limbs were stained with alizarin red and alcian blue 8GX
(0.3% alcian blue in 70% ethanol [1 ml]–0.1% alizarin red in 95% ethanol [1
ml]–glacial acetic acid [1 ml]–70% ethanol [17 ml]) for 2 days at 37°C and
transferred sequentially for 2- to 4-day periods through solutions of 1% KOH,
1% KOH–20% glycerol, 1% KOH–40% glycerol, 1% KOH–60% glycerol, and
1% KOH–80% glycerol at 4°C until, finally, destained limbs were stored in 100%
glycerol at 4°C prior to analysis and photography under a dissecting microscope.
In these preparations, mineralized bone is stained by alizarin red and cartilage is
stained by alcian blue 8GX. For mineralization analysis, tibias were dissected out,
fixed in 70% alcohol, embedded in paraffin, and cut (7 mm), and undecalcified
sections were stained according to the standard protocol (26). For histological
analyses, the paired limbs were fixed in 10% neutral buffered formalin for 4 to 6
days and subsequently decalcified for 2 days in 10% formic acid–10% neutral
buffered formalin at 20°C. Limbs were embedded in paraffin and 3-mm sections
were cut, deparaffinized in xylene, and rehydrated. Sections were stained with
hematoxylin and eosin or alcian blue 8GX and van Gieson to visualize cartilage
matrix mucopolysaccharides in blue and collagen-containing bone osteoid in red,
according to standard histological protocols.
Body temperature. The system we used, ELAMS (Electronic Laboratory An-
imal Monitoring System by BioMedic Data Systems, Inc., Seaford, Del.), con-
sisted of implantable programmable temperature transponders (IPTT-100) and
a portable data scanner (DAS-5007). The transponders were implanted subcu-
taneously in the backs of three 8- to 12-week-old males from each genotype.
Animals were maintained under anesthesia with midazolam. All animals were
kept in a climate-controlled room with 12-h alternating light and dark cycles.
Temperature measurements were initiated 3 days after the implantation and
were recorded in duplicate at 10 a.m., while the animals were moving freely in
their cage with the lid removed, and the scanner was placed within 5 cm of the
transponder. Body temperature monitoring continued for up to 7 days.
Temperature was measured rectally at the same time in TRa0/0b2/2 by means
of a digital recording with a thermistor system. Values were not significantly
different from those recorded by the transponder (data not shown).
Growth measurements. Male mice anesthetized with methoxyflurane were
weighed and measured (nose to tail base) weekly from 2 to 9 weeks of age. Mice
were housed five per cage, and food and water were provided ad libitum. The
numbers of mice used from each genotype were as follows: wild type, 19 to 29;
TRb2/2, 6 to 17; and TRa0/0, 10 to 22.
Hormone measurements. Serum T4 and TSH were measured by radioimmu-
noassays as previously described (29).
Hearing tests. The auditory brainstem response (ABR) was used to assess the
auditory sensitivity by a procedure that has been described in detail elsewhere
(35). Tucker-Davis Technologies (Gainesville, Fla.) hardware and software (AeP
and Siggen packages) were employed. Briefly, mice were anesthetized with so-
dium pentobarbital (Nembutal, 1.2 ml per g of body weight intraperitoneally
[i.p.]) and chlorprothixene (Taractan, 0.5 ml/g i.p.) and kept warm with a heating
pad. The average response (waveform) per 100 presentations of tone bursts (1 ms
rise and fall; 3 ms duration; rate, 21 Hz; frequencies of 4, 8, 12, 16, and 24 kHz)
was recorded using a subdermal needle electrode placed in the scalp. Each tone
frequency was presented in descending intensity steps beginning at 80-dB sound
pressure level and ending when a visually discernible ABR waveform could no
longer be detected. Thresholds were then determined to within 5 dB for each
frequency (35). The numbers of mice (60 to 90 days old) tested from each
genotype were as follows: wild type, 7; TRb2/2, 9; TRa0/0, 7; and combined
TRb2/2TRa0/0, 4.
Morphological staining and immunohistochemistry. Three-week-old mice
were killed by cervical dislocation and the small intestines were immediately
removed. Proximal jejunums and distal ilea were collected separately and fixed in
Carson’s solution overnight at 4°C. They were then embedded in paraffin and
5-mm sections were applied on polylysine-coated slides. For morphological ob-
servations, after dewaxing and rehydration, the slides were stained with hema-
toxylin and eosin.
Immunochemistry experiments were performed with a monoclonal antibody
(Novocastra Laboratories) for Ki-67 detection. Polyclonal antibody PAI-211
(Affinity Bioreagents, Inc.) for TRa1 and TRDa1 protein localization and an-
other recognizing the N-terminal part of both TRa1 and TRa2 proteins (gen-
erous gift of D. Baas [4]) were used in combination with secondary biotinylated
antibody and streptavidin-peroxidase detection system (Histomouse; Zymed).
The tissue was counterstained lightly with hematoxylin. Before incubation with
the primary antibody, the slides were immersed in 0.01 M citrate buffer, pH 6,
and microwaved for 15 min.
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Cells, plasmids, transfections, and Western blotting. HeLa cells were main-
tained in Dulbecco modified Eagle medium supplemented with 10% fetal calf
serum. The plasmids containing the cDNAs of human TRa1 (pSG5hTRa1), rat
TRb1 (pSG5rTRb1), mouse TRDa1 (pSG5mTRDa1), FlagTRDa1 (CMV-
FmTRDa1), and mouse TRDa2 (pSG5mTRDa2) have been described previ-
ously (6). HeLa cells were transfected using a calcium phosphate procedure as
previously described (7) and harvested after 48 h. Lactacystin was a gift from
Satoshi Omura (Tokyo, Japan). Western blotting was performed as previously
described (6). We used the no. 21 polyclonal antibody (gift of J. Ghysdael) as
described in reference 5 to detect TRa1 and TRDa1 proteins and the M2
anti-Flag antibody (IBI) to detect the Flag-TRDa1 protein.
RESULTS
The TRa0/0 mutation abolishes the production of all prod-
ucts from the TRa locus. To generate mice deprived of any
TRa gene product (TRa1 and TRa2 and their truncated coun-
terparts TRDa1 and TRDa2), a lacZ neor cassette (12) was
introduced by homologous recombination between exon 4 and
exon 8 of the TRa gene (Fig. 1A) to generate the TRa0 allele
(Fig. 1B). This removed the DNA binding region of TRa1 and
TRa2, preventing the production of a chimeric protein that
could act in a dominant-negative manner upon TRb. It also
removed the internal promoter in intron 7 which has been
shown to drive the transcription of TRDa1 and TRDa2 (6).
The TRa0 mutated allele was introduced into ES cells by ho-
mologous recombination. The structure of the modified allele
was checked by Southern blotting (Fig. 1C). Two independent
positive clones were injected into host blastocysts. Heterozy-
gous mice were derived from an inbred 129Sv genetic back-
ground. They were then intercrossed to obtain TRa0/0 mice.
We checked for the expression of TRa transcripts in wild-
type, TRa0/0, and previously described TRa2/2 mice (12). This
analysis was performed on intestine RNA where the four TRa
isoforms have been shown to be expressed. Northern blot anal-
ysis (Fig. 2A) showed that all four transcripts could be identi-
fied in the distal ileum of wild-type mice. In TRa2/2 mice,
TRa1 and TRa2 RNAs were undetectable, whereas the
TRDa1 and TRDa2 transcripts were still detected. In TRa0/0
mice, neither TRa nor TRDa transcripts were detected. In
agreement with these data, RT-PCR did not allow the detec-
tion of transcripts containing exons 8 and 9 in the intestines of
TRa0/0 mice (Fig. 2B). RNase protection analysis (Fig. 2C)
revealed that the TRa1 and TRa2 isoforms, which are highly
expressed in wild-type samples, are almost undetectable in
TRa2/2 and TRa0/0 samples. Occasionally, the 448- and 386-
nucleotide fragments were detected in the mutant mice, cor-
responding to transcription reading through the stop sites
within the lacZ neor cassette. It is noteworthy that RNase
protection showed that wild-type ileum contained similar
amounts of TRa1 and TRa2 transcripts. Underrepresentation
of the large TRa1 transcript in Northern blot experiments may
have been caused by poor transfer onto nylon membranes.
Two protected fragments, whose sizes correspond to the
TRDa1 and TRDa2 isoforms, were detected in wild-type and
TRa2/2 but not in TRa0/0 samples. It is thus concluded that in
the distal ileum of wild-type mice, four TRa isoforms are
expressed, including TRDa1 and TRDa2, which are expressed
at much lower levels than TRa1 and TRa2. The TRa0 muta-
tion completely abolishes the transcription from the TRa locus,
in contrast with the TRa mutation which still allows the pro-
duction of TRDa transcripts, as previously described (Fig. 2D).
TRa0/0 and TRa0/0b2/2 mice display normal embryonic
development and are viable. It has previously been shown that
TRa2/2 and TRa2/2b2/2 mice were born in Mendelian pro-
portions but died after weaning (12, 14). Lethality was found in
129SV, BALB/c, and C57BL/6 genetic backgrounds after eight
backcrosses. When TRa0/1 mice were intercrossed, among 346
born pups, 98 (28.3%), 170 (49%), and 78 (22.5%) were, re-
spectively, wild-type, heterozygous, and homozygous mutant
progenies. Unlike the TRa2/2 mice, all TRa0/0 mice survived
over the weaning period and the mortality in the adult popu-
lation was not different from that observed in the wild type.
Male and female TRa0/0 mice were fertile. Viability and fer-
tility were observed in C57BL/6 and 129SV backgrounds.
TRa0/0 mice were crossed with TRb2/2 mice to obtain TRa0/1
FIG. 1. Targeted disruption of the TRa gene by homologous recombination. (A) Structure of the TRa gene and of the various isoforms encoded
by this gene. The two transcription start sites are indicated by upper arrows. The differential splice site in exon 9 is indicated by a vertical bar. Exons
are numbered starting downstream to the distal promoter. Grey, coding regions. The structure of the transcripts is shown. (B) The targeted TRa0
allele contains a deletion extending from the middle part of intron 4 to the beginning of exon 8. The probe used for Southern blot analysis and
the size of the fragment detected after digestion with PvuII are indicated. (C) Detection of wild-type (1/1), heterozygous (0/1), and homozygous
(0/0) littermates by Southern blot analysis.
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b2/2 progenies. These mice were then intercrossed and their
progenies contained TRa0/0b2/1 and TRa0/1b2/2 animals
that were all viable. Because of the low fertility displayed by
TRa0/1b2/2 animals, only TRa0/0b2/1 mice were used to fur-
ther generate double-homozygous TR mutants (TRa0/0b2/2).
The proportion of TRa0/0b2/2 progenies was 19.5%. This
slight deviation from Mendelian ratios may reflect marginal
embryonic lethality or occasional improper maternal care for
TRa0/0b2/2 newborn mice. However, this result indicates that
TRs are not absolutely required for embryonic viability.
TRa0/0b2/2 mice survived beyond weaning time and were vi-
able for at least six months. Only occasionally were progenies
obtained from TRa0/0b2/2 intercrossings or from TRa0/0b2/2
males or females mated with wild-type partners, suggesting
that these animals have a very low fertility.
Deregulation of the pituitary-thyroid axis in TRa0/0b2/2
mice. The serum levels of T3 and T4 are strictly controlled by
the direct hormonal feedback on TSH-releasing hormone
(TRH) and TSH secretion, in the hypothalamus and the pitu-
itary, respectively (20, 24, 29). We and others have previously
demonstrated that TRb plays a key role in this feedback loop
since TRb2/2 mice display high T3, T4, and TSH levels (11, 14,
1). The role of TRa in this regulation has not been clearly
established. TRa12/2 mice demonstrated only a slight de-
crease of T4 and TSH concentrations in males (39), whereas
TRa2/2 mice presented a progressive but severe reduction of
circulating T4 and T3 between the third and the fourth week
after birth (12). In TRa0/0 adult males, basal concentration of
T4, but not T3 or TSH, is slightly but significantly reduced
compared to wild-type mice. Furthermore, TSH and T4 sup-
pression by increasing doses of T3 is more profound in TRa0/0
than in wild-type mice (25). In adult TRa0/0b2/2 mice, the
concentrations of serum T4, T3, and TSH were increased 14-
fold, 13-fold, and more than 200-fold respectively, compared to
FIG. 2. Expression of the different transcripts encoded by the TRa locus in the distal ilea of the different mutants. (A) A Northern blot assay
was performed using 20 mg of total RNA isolated from the distal ilea of animals carrying the indicated genotypes. The radiolabeled probe
hybridized to both TRa and TRDa transcripts. A glyceraldehyde-3-phosphate dehydrogenase or a hypoxanthine phosphorybosyl transferase probe
was used as an internal control. (B) Representative semiquantitative RT-PCR analysis of mRNAs encoded by the TRa locus in wild-type (WT),
TRa2/2, and TRa0/0 mice. The primers used allowed the amplification of both TRa and TRDa transcripts. HPRT was used as an internal control.
(C) RNase protection assay. Twenty micrograms of total distal ileum RNA from either wild-type, TRa0/0, or TRa2/2 mice was mixed with 75 fmol
of HPRT and 75 fmol of TRa RNA probes. The sizes of the protected TRa fragments and the positions of the TRa transcript isoforms are
indicated. (D) Summary of the TRa and TRDa mRNA expression in the distal ileum of each genotype.
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those of wild-type mice. These levels are comparable with
those previously reported for TRa12/2b2/2 animals (11-, 30-,
and 60- to 160-fold, respectively) (16) or 3-week-old TRa2/2
b2/2 mice (7-, 20-, and more than 100-fold, respectively) (14).
Reduced growth rate and delayed bone maturation in
TRa0/0 and TRa0/0b2/2 mice. The growth of TRa0/0 males and
their wild-type littermates was monitored over a two-month
period. TRa0/0 mice showed a reduced increase of body weight
compared to wild-type animals, at all ages analyzed, in both
129Sv (not shown) and C57BL/6 genetic backgrounds (Fig.
3A). The time course of linear growth displayed similar differ-
ences (Fig. 3B), showing that alteration of body growth fully
accounts for the weight differences and that the TRa0 mutation
does not result in an abnormal weight-to-length ratio. TRb2/2
mice displayed no difference in weight or length growth com-
pared to that of the wild type (Fig. 3A and B)
The growth of TRa0/0b2/2 mice was further reduced com-
pared to the TRa0/0 mutants, though no difference could be
observed at birth. Weight reductions of 50 and 30% were
observed in mice at weaning time and in adult mice, respec-
tively, compared to wild-type mice (Fig. 3C).
The synthesis of GH has been shown to be regulated by TH
and to be decreased in TRa12/2b2/2 mice (16), which display
marked growth retardation. We compared the expressions of
the GH mRNA in the pituitary glands of wild-type, TRa0/0,
and TRa0/0b2/2 mice. As shown in Fig. 3D, the amount of GH
RNA was not altered in TRa0/0 mice but was markedly re-
duced in double-knockout animals. These data suggest that the
reduced growth observed in TRa0/0 mice may not be due to a
reduced production of GH.
Since linear growth was affected in TRa0/0 mice, we studied
endochondral ossification in their long bones. For this purpose,
anatomical and histological analyses were performed. In
3-week-old TRa0/0 animals at weaning, the ends of metatarsals
and phalanges of the foot, the condyles and growth plate of the
femur, and the growth plates of the tibia and fibula stained
positively for cartilage with alcian blue (Fig. 4A). In wild-type
mice, alcian blue staining was markedly diminished and re-
placed by alizarin red staining in these areas, indicating that
bone formation and mineralization were more advanced than
in TRa0/0 animals. Furthermore, ossification of the patella was
delayed in TRa0/0 mice relative to that in wild-type mice (Fig.
4A). Similar evidence of delayed bone formation and miner-
alization was seen in the upper limbs of 3-week-old TRa0/0
mice (data not shown). Goldner staining of undecalcified lon-
gitudinal sections of tibias revealed that the ossification of the
epiphyses was delayed in TRa0/0 mice, and the density of
trabecular bone in the metaphyses was markedly lower than in
control mice (Fig. 4B). Histological analyses demonstrated
that tibial growth plates from TRa0/0 mice were grossly disor-
ganized compared to those of wild-type animals (Fig. 4B, C,
and D), and similar findings were observed in other growth
plates throughout the upper and lower limbs of TRa0/0 mice
(data not shown). In particular, proliferating growth plate
FIG. 3. Comparison of growth in wild-type and TRa- and TRb-deficient mice. Weight (A) and length (B) were measured weekly from 2 to 9
weeks and plotted as means 6 standard deviations. The numbers of animals are given in Materials and Methods. p, P , 0.01 for wild-type and
TRa0/0 mice. (C) Body weights of wild-type, TRa0/0, and TRa0/0b2/2 mice (in grams). (D) Northern blot analysis of pituitary GH mRNA from
wild-type, TRa0/0, and TRa0/0b2/2 mice. One to two micrograms of total RNA from individual pituitaries was loaded. Single-stranded DNA probes
for HPRT and GH were used.
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chondrocytes failed to form discrete columns and the hyper-
trophic zone was markedly diminished and morphologically
indistinct in TRa0/0 mice compared to wild-type mice, suggest-
ing that hypertrophic chondrocyte differentiation failed to
progress normally in TRa0/0 mice. Furthermore, the degree of
alcian blue staining of the growth plate cartilage matrix in
TRa0/0 mice was diminished and patchy compared to that in
wild-type animals, supporting the view that epiphyseal growth
plate architecture is disorganized and endochondral ossifica-
tion is disrupted in TRa0/0 mice (Fig. 4C and D). In TRa0/0
b2/2 mice, a similar phenotype was observed (data not shown).
These alterations were similar to those described previously for
TRa2/2 and TRa2/2b2/2 mice (12, 14) and are reminiscent of
abnormalities in epiphyseal growth plates of hypothyroid rats
(34).
TRa0/0b2/2 mice display severe hypothermia. TH plays a
crucial role in the control of thermogenesis, and hypothyroid-
ism results in decreased oxygen consumption and heat produc-
tion (13). We examined the temperatures of adult wild-type
and mutant mice, using both a rectal probe and a temperature-
sensitive probe implanted under the skin. The two techniques
provided similar data. The mean body temperature of TRb2/2
mice was similar to that of wild-type mice, but it was 0.4°C
lower in TRa0/0 mice (Fig. 5). Interestingly, the mean body
temperature of TRa0/0b2/2 animals was dramatically de-
creased (24°C) relative to that of the wild type (Fig. 5). These
data suggest functional redundancy between the TRb and the
TRa loci in the control of basal body temperature.
Decrease of auditory sensitivity in TRa0/0 mice and deafness
in TRa0/0b2/2 mice. Several authors have described deafness
FIG. 4. Morphological appearance of lower limbs and tibial growth plates in 3-week-old wild-type (wt) and TRa gene knockout (a0/0) animals.
(A) Lower-limb skeletal mounts stained with alizarin red and alcian blue 8GX showing feet (left) and knee joint including lower femur and upper
tibia with fibula (right); magnification, 38. Red staining shows mineralized bone and blue shows cartilage growth plates; the patella is shown to
the right of each knee joint and is stained red in the wt, indicating that mineralization is complete, but blue in TRa0/0, demonstrating the persistence
of cartilage. (B) Longitudinal medial bone sections stained with modified Goldner of TRa1/1 (wt) and TRa0/0 mice. Mineralized matrix is stained
in green. E, epiphysis; D, diaphysis; horizontal arrows, growth plate. (C and D) alcian blue 8GX and van Gieson staining of proximal tibial growth
plates from wt and TRa0/0 mice; a section through the whole growth plate (magnification, 3200) is shown in panel C and a section containing the
distal half of the growth plate (magnification, 3400) is shown in panel D. Black arrows, resorption front which separates the growth plate from
underlying primary spongiosum; e, epiphysis; ps, primary spongiosum; rz, reserve zone chondrocytes; pz, proliferative zone; hz, hypertrophic zone.
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in mice lacking both TRb1 and TRb2, but not in mice lacking
TRb2 only or TRa1 (1, 11), suggesting that TRb1 is the only
mediator of this T3-dependent function. However, the role of
TRa2 and the effect of the double knockout on the integrity of
hearing have not been documented. We therefore measured
the ABR threshold in TRa0/0 and TRa0/0b2/2 mice. Whereas
at low or middle frequencies TRa0/0 mice had a normal hear-
ing threshold, they exhibited a marked loss of sensitivity at high
tone frequencies (Fig. 6). In TRa0/0b2/2 mice, the loss of
hearing threshold was significantly more severe than that ob-
served in TRb2/2 animals. These data suggest that, although
the TRb1 receptor is the major mediator of T3 action, in
addition the integrity of the TRa gene is required to achieve
full function of the auditory apparatus.
The intestinal phenotype is mildly altered in TRa0/0 mice
compared to that of TRa2/2 mice. In mammals, the small
intestine is lined by a continuously renewable population of
epithelial cells. The pluripotent crypt stem cells give rise to
immature cells that migrate and differentiate in the villus com-
partment and die after exfoliation at the villus tip. It was
previously demonstrated that TRa2/2 mice displayed a strong
impairment of postnatal intestinal development (14, 28). It is
noteworthy that the intestine is one of the few organs where
the TRDa and the TRa isoforms are coexpressed. In order
to differentiate functions of the TRa1/a2 and TRDa1/Da2
isoforms in the intestine epithelium, we carried out a compar-
ative investigation of morphofunctional parameters in TRa0/0,
TRa2/2, and wild-type mice.
The size of the small intestine mucosa was reduced in
TRa0/0 mutants compared to that of wild-type animals. This
was mainly due to the reduced lengths of the villi, resulting
from a decreased number of epithelial cells per crypt-villus axis
(Fig. 7A and B). These features were more strongly affected in
the TRa2/2 mice (Fig. 7C). The proliferation and differenti-
ation parameters of the epithelial cells also indicated a stron-
ger impairment in TRa2/2 than in TRa0/0 mice (27a). In
contrast to the TRa2/2 mutant animals that displayed a thin-
ning of the smooth muscular layers (12, 28), TRa0/0 mutants
appeared normal in this respect. Taken together, these data
strongly suggest that the severity of the intestinal phenotype
correlates mostly with the persistence of the TRDa transcripts
and not with the absence of TRa1 and TRa2 isoforms.
The intestinal phenotype is more severe in TRa2/2b2/2
than in TRa0/0b2/2 mice. It was previously shown that com-
bining the TRa2 and TRb2 mutations in TRa2/2b2/2 mice
results in a more dramatic alteration of the structure of the
FIG. 5. Body temperature was measured at 10 a.m. with implant-
able transponders for 7 days in at least 3 male mice aged 8 to 12 weeks
for each of the wild-type (WT) TRb2/2, TRa0/0, and TRa0/0b2/2
genotypes. Each bar represents a mean value (6 standard deviation).
Body temperatures of TRa0/0 and TRa0/0b2/2 animals were statisti-
cally different from those of wild-type control animals (P , 0.001 and
P , 0.001, respectively, by the Student t test).
FIG. 6. ABR threshold in wild-type and TR gene knockout mice. The average response per 100 presentations of tone bursts (1 ms rise and fall;
3 ms duration; rate, 21 Hz; frequencies of 4, 8, 12, 16, and 24 kHz) were recorded. The numbers of animals are given in Materials and Methods.
At all frequencies the difference between wild-type and TRb2/2 and TRa0/0b2/2 mice was P , 0.001. Solid lines, P values for differences between
TRb2/2 and TRa0/0b2/2; dashed line, P values for differences between the wild type and TRa0/0.
4754 GAUTHIER ET AL. MOL. CELL. BIOL.
distal ileum than that observed in TRa2/2 mice (14, 28). When
we analyzed the distal ilea of TRa0/0b2/2 versus those of
TRa0/0 mice, no obvious morphological difference was ob-
served (Fig. 7B and D) and no statistically significant difference
was found in the number of epithelial cells per crypt-villus axis.
In contrast, in the ilea of TRa2/2b2/2 mice, the number of
epithelial cells was further decreased compared with that of
TRa2/2 mice (Fig. 7C and E) and the morphology was dra-
matically altered (Fig. 7E), in agreement with previous obser-
vations. The number of proliferating cells in the crypts of
TRa0/0b2/2 mice (8 6 1) was decreased to the same extent as
in TRa0/0 animals (7 6 1). In contrast, this number was more
reduced in TRa2/2b2/2 (2 6 1) than in TRa2/2 animals (5 6
1). The analysis of epithelial cell differentiation markers also
demonstrated similar features in TRa0/0 and TRa0/0b2/2 an-
imals but showed a stronger impairment in TRa2/2b2/2 than
in TRa2/2 mice. In summary, the knockout of the TRb gene
does not worsen the phenotype observed in TRa0/0 mice, but
clearly enhances the alterations observed in TRa2/2 mice.
These data rule out functional redundancy between TRs in the
control of postnatal development of the intestine. They suggest
instead that the expression of the TRDa isoforms, which is
deleterious in the absence of TRa1 and TRa2, has even more
toxic effects in the absence of all TRs.
Identification of the TRDa proteins in the distal ileum by
immunohistochemistry. The intestinal epithelium is composed
of proliferating and undifferentiated cells which form the crypt
compartment and of mature cells located in the villi. In order
to analyze the presence of the TRDa proteins in the intestinal
mucosa and their pattern of expression along the crypt-villus
axis, we performed immunocytochemical analysis. Since TRDa
proteins do not contain any peptide sequence which would
differentiate them from their complete TRa counterpart, we
had to compare the patterns in distal ilea from wild-type,
TRa2/2, and TRa0/0 mice, using the following antisera: anti-
Ca1 raised against the common C-terminal part of TRa1 and
TRDa1, anti-Ca2 raised against the common C-terminal part
of TRa2 and TRDa2 but different from TRa1, and anti-Na
raised against the N-terminal part common to TRa1 and
TRa2. No staining was obtained with the anti-Ca2 antibody in
any genotypes (data not shown), whereas the expression of
TRa2 and TRDa2 mRNAs has been demonstrated by semi-
quantitative RT-PCR (28), Northern blotting, and RNase pro-
tection (this study) in wild-type mice. As this antiserum was
FIG. 7. Morphological appearance of distal small intestine in 3-week-old animals. Sections (5 mm) from wild-type (A), TRa0/0 (B), TRa2/2 (C),
TRa0/0b2/2 (D), and TRa2/2b2/2 (E) mice were stained with hematoxylin and eosin. The numbers at the right of each picture indicate the number
of epithelial cells per crypto-villus axis. Statistical analysis indicated that the number of the epithelial cells in TRa2/2, TRa0/0b2/2, and
TRa2/2b2/2 animals was significatively decreased compared to that in wild-type mice (P , 0.001, P , 0.05, and P , 0.0001, respectively, by the
Student t test; n 5 5). In addition, the number of epithelial cells was also significantly decreased in TRa2/2b2/2 compared to TRa2/2 mice (P ,
0.001 by the Student t test). Bar, 30 mm.
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used successfully in immunocytochemical detection of TRDa2
and TRa2 proteins in transfected cells (data not shown), the
failure to detect these proteins in the small intestine probably
results from their very low concentration in this tissue.
Using the anti-Na antiserum, we observed a nuclear labeling
in muscle layers of wild-type mice (Fig. 8A to D), but no
staining was observed in the epithelium or mesenchyme (Fig.
8B and C). No positive cells were detected in TRa0/0 or
TRa2/2 mice (Fig. 8E to H and I to L). By semiquantitative
RT-PCR, it was previously shown that in smooth muscle layers
only the TRa1 RNA was detected (28). Consequently, the
signal detected with the anti-Na antibody in this tissue can be
attributed to TRa1. In the same experiment, the TRa1 mRNA
was found in the epithelium and connective tissues, whereas
the TRa2 mRNA was found only in the epithelium (28); there-
fore, we assume that the corresponding proteins are expressed
in these tissue regions but at levels undetectable by this tech-
nique.
Using the anti-Ca1 antibody, we detected a strong nuclear
signal in the differentiated epithelial cells of the villi in wild-
type mice (Fig. 9A and B). Only a faint signal could be de-
tected in the undifferentiated epithelial cells of crypts, in the
lamina propria, and in smooth muscle cells (Fig. 9C and D).
However, unlike the signal detected with the anti-Na reagent,
this staining persisted in TRa2/2 mice (Fig. 9I to L), which
retain the expression of TRDa transcripts, and disappeared in
TRa0/0 mice (Fig. 9E to H). These observations demonstrate
that the protein labeled by the anti-Ca1 reagent is TRDa1.
They also suggest that, unlike the anti-Na antibody, the anti-
Ca1 antibody is unable to recognize the TRa1 protein, pre-
sumably due to the small amount of this protein in the distal
ileum, and to the reduced accessibility of the target epitope in
the tight conformation of the ligand binding domain. Alto-
gether, these data indicate that in wild-type mice, the TRa1
protein is mainly located in the nuclei of smooth muscle cells,
whereas the TRDa1 protein is mainly present in the nuclei of
differentiated epithelial cells. It is worth noting that in TRa2/2
undifferentiated and differentiated epithelial cells have similar
nuclear labeling.
The activity of TRDa proteins is down-regulated by TRa1
via the proteasome pathway. Our data show that the deleteri-
ous activity of the TRDa isoforms is triggered by the inactiva-
tion of the TRa1 and TRa2 genes. To clarify the molecular
mechanisms which could account for this gene inactivation-
dependent activity, we tested the possibility that TRa1 and
TRa2 could interfere with the synthesis or degradation of the
TRDa isoforms, thereby modulating their activity. For this
purpose, we measured the expression of the TRDa1 protein in
HeLa cells after cotransfection of a TRDa1 expression vector
together with either an empty vector or a vector expressing
either TRa1 or TRa2. Figure 10 shows that, while the amount
of TRDa1 transcripts was unaffected by the coexpression of the
TRa1 protein (Fig. 10C), the amount of TRDa1 protein was
reduced by increasing amounts of TRa1 (Fig. 10A). This effect
was independent of the presence of T3 (data not shown). In
contrast to these data, the expression of small amounts of
TRa2 did not produce any decrease in the amount of TRDa1
protein (Fig. 10B). It is noteworthy that expression of TRb1
did not change the amount of TRDa1 (data not shown). In
order to show that degradation, and not the rate of protein
synthesis, accounted for the reduction in the amount of the
TRDa1 protein, we tested the abilities of different permeant
protease inhibitors to prevent this effect. When cotransfected
cells were treated with lactacystin, a potent inhibitor of the
proteasome pathway (9), the amount of TRa1 protein was not
changed, but the amount of TRDa1 protein was considerably
FIG. 8. Immunolocalization of TRa1/TRa2 proteins. The pattern of expression of TRa proteins of distal ileum was analyzed in paraffin-
embedded sections (5 mm) in wild-type (A to D), TRa0/0 (E to H), and TRa2/2 (I to L) 3-week-old mice. The antibody used recognizes the
N-terminal part common to TRa1 and TRa2 (anti-Na) on wild-type sections (B to D), TRa0/0 (F to H), and TRa2/2 (J to L). Technical controls
included the use of phosphate-buffered saline or nonimmune serum instead of the primary antibody. (A, E, and I) Phase contrast low magnifi-
cation; bar, 30 mm; (B to D, F to H, and J to L) bright field high magnification; bar, 70 mm. ce, crypt epithelium; ve, villus epithelium; ct, connective
tissue; cml, circular muscle layer; lml, longitudinal muscle layer.
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increased, reaching levels higher than those observed in the
absence of TRa1 (Fig. 10D). These data suggest that TRa1
triggers the degradation of the TRDa1 protein through a pro-
teasome-dependent pathway.
DISCUSSION
The TRa locus encodes the TRa1 receptor, whose targeted
inactivation results in bradycardia and a slight decrease in body
temperature (39). This locus also generates the TRa2 variant,
which cannot bind T3, poorly heterodimerizes with RXRs, and
does not contain any transactivation domain. Transfection
studies have shown that the TRa2 protein can inhibit the
transcriptional activity of TRs. The TRa2 transcript is present
in all mammalian tissues and is generally more abundant than
the TRa1 transcript, at least at the level of whole organ anal-
ysis (22). Despite these many data, the in vivo function of the
TRa2 protein remains unknown. In addition to TRa1 and
TRa2, we have identified the TRDa1 and TRDa2 transcripts,
which are expressed in murine embryonic stem cells and in
intestine, lung, and brain tissues of adult mice. The proteins
encoded by these transcripts do not bind T3 or DNA but
inhibit the transcriptional activity of several nuclear receptors
when they are associated with RXR partners (6). Their in vivo
function is unknown. Several genetic modifications of the TRa
locus which have been generated in a mouse now provide tools
with which to obtain insights into the functions of these differ-
ent products. The goal of this discussion is to draw some
conclusions from the comparison of the phenotypes observed
in the different TRa gene knockout mice. For the sake of
clarity, we have indicated in Fig. 2C the TRa isoforms which
are expressed or abolished in the different knockout strains.
TRa1 and TRbs cooperate to regulate TSH production.
Abolishing a TRb1, TRb2, TRb3 and TRDb3, or TRb2 only
has been shown to result in altered TH-dependent feedback
regulation of TSH production by T3 (1, 37). In contrast, abol-
ishing the TRa1/Da1 isoforms in TRa12/2 mice (R. E. Weiss,
O. Chassande, P. E. Macchia, K. Cua, J. Samarut, and S. E.
Refetoff, submitted for publication), TRa1/a2 in TRa2/2 mice
(12), or TRa1/a2/Da1/Da2 in TRa0/0 mice (25) results in mild
alterations in the serum concentrations of TH and TSH, indi-
cating that the TRa isoforms may play minor roles in this
feedback control. However, TRa12/2 mice display decreased
T4 and TSH levels, suggestive of secondary hypothyroidism,
while TRa0/0 mice have decreased T4 but normal TSH levels,
indicating increased sensitivity of the pituitary to TH. More-
over, careful examination of central responses to varying doses
of T3 in TRa0/0 mice reveals increased sensitivity to TH (25).
Altogether, these data suggest that the TRa2 isoform weakly
antagonizes the activity of TRbs in thyrotroph cells. In the
absence of any true TRs, in TRa12/2b2/2 (16), TRa2/2b2/2
(14), and TRa0/0b2/2 mice, TSH reaches very high levels de-
spite large amounts of TH, independently of the presence of
non-T3-binding TR isoforms. This shows that in thyrotroph
cells, TRa2 could modulate TSH production only in the pres-
ence of a TRb-mediated T3 response.
TRa1, TRa2, and TRbs cooperate to maintain basal body
temperature. Mice lacking the TRa1/Da1 isoforms (TRa12/2)
have a body temperature 0.5°C lower than that of wild-type
mice (18). We show here that TRa0/0 mice display a similar
deficit, suggesting that abolishing TRa2 does not alter ther-
mogenesis, at least under basal conditions. TRb2/2 mice have
normal body temperatures suggesting that the contribution of
the TRb isoforms in the T3-dependent basal thermogenesis is
FIG. 9. Immunolocalization of TRDa1 protein. Its pattern of expression in distal ileum was analyzed in paraffin-embedded sections (5 mm) in
wild-type (WT) (A to D), TRa0/0 (E to H), and TRa2/2 (I to L) 3-week-old mice. The antibody recognized the C-terminal sequence common to
TRa1 and TRDa1 (anti-CaI) on WT (B to D), TRa0/0 (F to H) and TRa2/2 (J to L). Technical controls included the use of phosphate-buffered
saline or the antibody preincubated with an excess of the recognized peptide. (A, E, and I) Phase contrast low magnification; bar, 30 mm; (B to
D, F to H, and J to L) bright field high magnification; bar, 70 mm. ce, crypt epithelium; ve, villus epithelium; ct, connective tissue; cml, circular
muscle layer; lml, longitudinal muscle layer. The open arrow in C indicates the stronger nuclear staining of cells outside the crypts.
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minor or compensated for by TRa1. Surprisingly, the compar-
ison between body temperature deficits observed in TRa12/2
b2/2 (2 0.5°C) and TRa0/0b2/2 (24°C) mice reveals poten-
tially important thermogenic functions for the TRa2 isoform.
Since no difference in body temperature is observed between
TRa12/2 and TRa0/0 mice, this function is unraveled only in
the absence of functional TR. The above data lead to the
conclusion that the effects of TH on basal body temperature
are mediated by the TRa and TRb nuclear receptors, that
TRa1, TRbs, and TRa2 isoforms exercise redundant functions
in the control of thermogenesis, and that the persistence of
only one of these isoforms is sufficient to maintain body tem-
perature within a physiologic range.
TRa2 is essential for normal body growth and bone matu-
ration. Previous publications and our data have shown that in
TRa2/2b2/2, TRa12/2b2/2, and TRa0/0b2/2 mice, the total
absence of functional TH receptors results in a reduced growth
rate and delayed bone maturation, independently of the pres-
ence of non-TH-binding isoforms from the TRa locus. This
consensus is in agreement with the bone maturation delay
observed in hypothyroid rats (34). This simple observation
contrasts with the complexity resulting from the analysis of the
functions of individual TRa and TRb isoforms. Previous re-
ports indicate that TRb2/2 and TRa12/2 mice have normal
growth rates and bone maturation (10, 14, 16, 39). In contrast,
combining some of the TR mutations results in a profound
disruption of these processes, revealing functional redundan-
cies between TR isoforms. One redundancy clearly occurs with
TRa1 and TRb, which are both expressed in bone (2, 5, 31, 34)
and which in combined but not individual knockouts result in
bone maturation delay. The selective abolishing of TRa1 in
TRa12/2 mice does not result in obvious impairment of linear
growth or bone maturation. However, in TRa2/2 (12) and
TRa0/0 (this paper) mice, devoid of both TRa1 and TRa2
isoforms, growth retardation and delayed skeletal develop-
ment are observed. The skeletal phenotype of TRa0/0 mice
includes retarded ossification, failure of progression of hyper-
trophic chondrocyte differentiation, and disorganization of
epiphyseal growth plate architecture, all features similar to
those seen in hypothyroidism (34). Importantly, circulating
FIG. 10. Regulation of the stability of TRDa1 protein in HeLa cells. (A) Effects of increasing amounts of the expression vector pSG5hTRa1
(0, 1.5, 5, and 15 mg) on the TRDa1 protein (plasmid CMV-FmTRDa1, 0.3 mg) as analyzed by Western blotting. HeLa cells were lysed after 48 h
of transient transfection. The no. 21 antibody diluted 1:1,000 revealed both TRa1 and FTRDa1 proteins as indicated by the arrows. (B) Effects
of increasing amounts of the expression vector pSG5hTRa2 (0, 1.5, 5, and 15 mg) on the TRDa1 protein (plasmid CMV-FmTRDa1, 0.3 mg) as
analyzed by Western blotting. (C) Effect of cotransfection in HeLa cells of 15 mg of pSG5hTRa1 and 0.3 mg of CMV-FmTRDa1 on FTRDa1
mRNA expression analyzed by RT-PCR. RNA was prepared from HeLa cells after 48 h of transient transfection. HPRT was used as internal
control. (D) Effect of lactacystin addition (1025 M) in culture medium of HeLa cells transiently transfected with 0.3 mg of CMV-FmTRDa1 and/or
15 mg of pSG5hTRa1 expression vectors. The crude protein lysate was analyzed by Western blotting and the FTRDa1-specific band was revealed
with an anti-Flag antibody diluted 1:1,000. The bands in the middle and upper parts of the picture represent nonspecific staining. In transient
transfection experiments a total of 15 mg of DNA/dish has been used; when necessary the pSG5 empty vector has been added.
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basal TH concentrations in TRa0/0 mice were only mildly im-
paired and GH concentrations were unchanged compared to
those of wild-type mice, supporting the notion that the deletion
of the TRa gene fully accounts for this phenotype. On consid-
eration of the TR isoforms that are expressed in the different
knockout strains (Fig. 2C), the skeletal phenotypes described
can be proposed to result primarily from the abolishing of
TRa2, or the concomitant abolishing of both TRa1 and TRa2.
Only when data concerning the TRa2-specific mutation are
available will it be possible to test this hypothesis further.
Nevertheless, our data reveal the important role of TRa2 in
body growth and maturation of long bones. An interesting
observation is that in bone, abolishing TRa2, an isoform that is
known to weakly inhibit T3 responses in vitro, paradoxically
results in a phenotype which is similar to the skeletal conse-
quences of profound hypothyroidism. This situation contrasts
with the increased T3 response observed in the pituitary of
TRa0/0 mice (25). The alteration of growth and bone matura-
tion observed in TRa12/2b2/2 and TRa0/0b2/2 mice could be
attributed to impaired GH synthesis since these animals exhibit
decreased amounts of GH transcripts in pituitary (reference 16
and the present study). In TRa0/0 and TRa2/2 mice, however,
the GH transcript is expressed at a normal level; therefore, the
bone phenotype may be the direct consequence of the TRa
mutation within bone cells.
Deafness caused by loss of the TRb gene is not rescued by
deletion of the TRa gene. In addition to confirming the impor-
tance of TRb in achieving normal hearing function, the present
studies demonstrate that TRa may also play a role in the
development of normal hearing. In fact, a reduced hearing
ability was observed in TRa0/0 mice compared to that of wild-
type mice at higher frequencies. Although some elevation of
ABR thresholds at 24 kHz is typical of C57BL/6J mice older
than 2 to 3 months, the observed hearing loss in the TRa0/0
mice is highly significant. Moreover, the TRa0/0b2/2 mouse
was more severely deaf than the TRb2/2 mouse. While these
observations confirm the important role of TRb for the devel-
opment of auditory function (12), they have also identified a
contribution of TRa to the full integrity of hearing.
Unbalanced expression of TRDa isoforms results in im-
proper intestinal development and precocious lethality. We
have previously described the lethal phenotype of TRa2/2
mice. The TRa2 mutation abolishes the TRa1 and TRa2 tran-
scripts but retains TRDa transcripts. We show in this study that
TRDa transcripts are expressed in the small intestines of wild-
type and TRa2/2 but not of TRa0/0 mice. Accordingly, using
anti-a1 C-terminal antibody, we detect the TRDa isoforms in
the intestinal epithelial cells of wild-type and TRa2/2 but not
TRa0/0 mice. This is the first time that the specificity of the
staining observed in an immunocytochemical analysis of TRs is
assessed by genetic arguments. Therefore, analysis of the prod-
ucts of the TRa locus reveals that the only molecular difference
between the TRa2/2 and TRa0/0 mutations is the expression
of the TRDa isoforms. Immunocytochemical analysis further
shows that the expression of the TRDa1 protein is expanded in
the TRa2/2 mice, extending all along the crypt and the villus.
In vivo observations show that abolishing TRa1 and TRa2 in
TRa2/2 mice confers deleterious effects on the TRDa iso-
forms, suggesting that, under normal conditions (wild-type
mice), the TRa products down-modulate the activity of the
TRDa isoforms. Transfection experiments suggest that one
mechanism by which TRs could control the activity of TRDa
proteins is by triggering their rapid removal from the cells
through the proteasome-mediated degradation. This mecha-
nism would explain the increased intensity and extended ex-
pression domain of the TRDa1 protein in the absence of TRa1
in the intestines of TRa2/2 mice. The mechanism by which
TRDa proteins exert their toxic effects in the developing in-
testine is unclear. The persistence of a severe intestinal phe-
notype upon inactivation of the TRb gene in TRa2/2b2/2
mice implies that the molecular targets of the TRDa proteins
are not only the TRs. We have previously suggested that other
nuclear receptors, such as retinoic acid receptors, could be
antagonized by TRDa products.
At the level of the whole organism, the lethal phenotype
observed in TRa2/2 and TRa2/2b2/2 mice is indeed due to
the persistence of TRDa isoforms since it can be rescued by
their abolition in TRa0/0 and TRa0/0b2/2 mice. Thus, the
severe intestinal abnormalities and the lethality observed in
TRa2/2 and TRa2/2b2/2 mice are consequences of the per-
sistence of TRDa isoforms, which are no longer under the
control of the TRa1 protein. These genetic and molecular
analyses suggest that the TRDa isoforms have powerful, dose-
dependent toxic effects and that their level of expression must
be tightly controlled. Altogether, these genetic analyses show
that the non-T3-binding isoforms encoded from the TRa locus
have important developmental and homeostatic functions.
In addition, our present and previously published data allow
the prediction that a potential homozygous mutation in the
TRa locus in humans, which would abolish all TRa isoforms,
would be expected to result in a mild phenotype mainly char-
acterized by (i) increased sensitivity to TH in the thyrotroph
and liver and (ii) reduced sensitivity to TH in heart and bone,
manifested as bradycardia, growth retardation, and bone mat-
uration delay. Mutations restricted to the N-terminal moiety of
the gene, sparing the TRDa isoforms, are expected to have
severe pathologic consequences.
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